Cargando…

Analysis of the efficacy of autologous peripheral blood stem cell transplantation in high-risk neuroblastoma

Objective: This study aimed to analyze the efficacy of autologous peripheral blood stem cell transplantation for high-risk neuroblastoma in China. Methods: The data of 90 high-risk neuroblastoma patients treated with the CCCG-NB 2015 regimen were reviewed. The baseline clinicopathological characteri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Jin, Jie, Li, Jiaxing, Yang, Yanna, Cao, Zhanglin, Li, Zhongyuan, Li, Daowei, Wang, Guangzong, Zhao, Benfu, Zhong, Jie, Yan, Qiang, Zhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553861/ https://www.ncbi.nlm.nih.gov/pubmed/36237985 http://dx.doi.org/10.7150/ijms.76305

Ejemplares similares

Polo-like kinase 4 mediates epithelial–mesenchymal transition in neuroblastoma via PI3K/Akt signaling pathway
por: Tian, Xiangdong, et al.
Publicado: (2018)

Clinical evaluation of integrated panel testing by next-generation sequencing for somatic mutations in neuroblastomas with MYCN unamplification
por: Cao, Yanna, et al.
Publicado: (2017)

A single center clinical analysis of children with high-risk neuroblastoma
por: Tian, Xiangdong, et al.
Publicado: (2017)

Research progress of neuroblastoma related gene variations
por: Cao, Yanna, et al.
Publicado: (2016)

Autologous stem cell transplantation for the treatment of neuroblastoma in Korea.
por: Ryu, Kyung Ha, et al.
Publicado: (2003)

A novel ganglioside-related risk signature can reveal the distinct immune landscape of neuroblastoma and predict the immunotherapeutic response
por: Yang, Jiaxing, et al.
Publicado: (2022)

Value of pretreatment 18F-FDG PET/CT in prognosis and the reflection of tumor burden: a study in pediatric patients with newly diagnosed neuroblastoma
por: Man, Shuai, et al.
Publicado: (2021)

Autologous Stem-Cell Transplantation for High-Risk Neuroblastoma: Historical and Critical Review
por: Mora, Jaume
Publicado: (2022)

Anlotinib Induces a T Cell–Inflamed Tumor Microenvironment by Facilitating Vessel Normalization and Enhances the Efficacy of PD-1 Checkpoint Blockade in Neuroblastoma
por: Su, Yudong, et al.
Publicado: (2022)

Pediatric high risk neuroblastoma with autologous stem cell transplant – 20 years of experience
por: Khan, Saadiya, et al.
Publicado: (2021)

Sam68 is a novel marker for aggressive neuroblastoma
por: Zhao, Xiaohong, et al.
Publicado: (2013)

Mechanisms of endothelial injury and transplant-associated thrombotic microangiopathy in tandem autologous hematopoietic stem cell transplant for neuroblastoma
por: Sabulski, Anthony, et al.
Publicado: (2023)

Graft-versus-host disease in a child with neuroblastoma after autologous stem cell transplantation
por: Yaman, Yöntem, et al.
Publicado: (2019)

An unexpectedly high incidence of Epstein–Barr virus lymphoproliferative disease after CD34+ selected autologous peripheral blood stem cell transplant in neuroblastoma
por: Powell, J L, et al.
Publicado: (2004)

Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants
por: Bottino, Cristina, et al.
Publicado: (2022)

Impact of Autologous and Allogeneic Stem Cell Transplantation in Peripheral T-Cell Lymphomas
por: Reimer, Peter
Publicado: (2010)

Autologous stem cell transplantation as frontline strategy for peripheral T-cell lymphoma: A single-centre experience
por: Han, Xiao, et al.
Publicado: (2017)

Myeloablative treatment supported by autologous stem cell infusion with neuroblastoma.
por: Ryu, Kyung Ha, et al.
Publicado: (2003)

Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation.
por: Combaret, V., et al.
Publicado: (1989)

Autologous peripheral blood stem cell transplantation as front-line therapy for myeloma with double-hit and triple-hit in a real-world study
por: Yang, Guang-Zhong, et al.
Publicado: (2021)

Autologous or allogeneic hematopoietic stem cells transplantation combined with high-dose chemotherapy for refractory neuroblastoma: A protocol for systematic review and meta-analysis
por: Zhao, Zhang-Shuai, et al.
Publicado: (2021)

Retrospective Analysis of Peripheral Blood Stem Cell Transplantation for the Treatment of High-Risk Neuroblastoma
por: Kim, Eun Kyung, et al.
Publicado: (2007)

Efficacy and Safety of Nivestim Versus Neupogen for Mobilization of Peripheral Blood Stem Cells for Autologous Stem Cell Transplantation
por: Chew, Cindy, et al.
Publicado: (2019)

Acute Response of Peripheral Blood Cell to Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetic Patient
por: Zhang, Xiaofang, et al.
Publicado: (2012)

Immunotherapy with low-dose recombinant interleukin 2 after high-dose chemotherapy and autologous stem cell transplantation in neuroblastoma.
por: Pession, A., et al.
Publicado: (1998)

Allogeneic stem cell transplantation for neuroblastoma
por: Sung, Ki Woong
Publicado: (2012)

Efficacy of autologous bone marrow mononuclear cell transplantation therapy in patients with refractory diabetic peripheral neuropathy
por: Mao, Hong, et al.
Publicado: (2019)

Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 study.
por: Philip, T., et al.
Publicado: (1993)

A retrospective study of autologous hematopoietic stem cell transplantation for peripheral T-cell lymphoma: pre-transplant patients with partial remission benefit from post-transplant maintenance therapy
por: Huang, Zhenghua, et al.
Publicado: (2023)

Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus
por: Ye, Lei, et al.
Publicado: (2017)

Outcome and Prospective Factor Analysis of High-dose Therapy Combined with Autologous Peripheral Blood Stem Cell Transplantation in Patients with Peripheral T-cell Lymphomas
por: Wu, Meng, et al.
Publicado: (2018)

Autologous hematopoietic stem cell transplantation improves survival outcomes in peripheral T-cell lymphomas: a multicenter retrospective real-world study
por: Wu, Meng, et al.
Publicado: (2023)

Pleuroparenchymal fibroelastosis secondary to autologous peripheral blood stem cell transplantation: A case report
por: Egashira, Ayaka, et al.
Publicado: (2023)

Autologous transplantation with fewer fibers repairs large peripheral nerve defects
por: Deng, Jiu-xu, et al.
Publicado: (2017)

Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-G(D2) immunotherapy and isotretinoin
por: Kushner, Brian H., et al.
Publicado: (2015)

The Role of Autologous Stem-Cell Transplantation in High-Risk Neuroblastoma Consolidated by anti-GD2 Immunotherapy. Results of Two Consecutive Studies
por: Mora, Jaume, et al.
Publicado: (2020)

Comparison of CEAC, BEAM and IEAC conditioning regimens followed by autologous stem cell transplantation in peripheral T-cell lymphoma patients
por: Xiong, Yi-Ying, et al.
Publicado: (2022)

Induced Autologous Stem Cell Transplantation for Treatment of Rabbit Renal Interstitial Fibrosis
por: Ruan, Guang-Ping, et al.
Publicado: (2013)

A multicenter retrospective study on the real-world outcomes of autologous vs. allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphoma in China
por: Gu, Zhen-Yang, et al.
Publicado: (2021)

Autologous Mesenchymal Stem Cell Transplantation in Multiple Sclerosis: A Meta-Analysis
por: Zhou, Yang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bn5ki4l0t0uhikmbrj5er5tipq